KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Interest Coverage Ratio (2019 - 2025)

Historic Interest Coverage Ratio for Esperion Therapeutics (ESPR) over the last 7 years, with Q3 2025 value amounting to 0.45.

  • Esperion Therapeutics' Interest Coverage Ratio rose 5749.68% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year decrease of 23184.59%. This contributed to the annual value of 0.92 for FY2024, which is 13480.87% up from last year.
  • Esperion Therapeutics' Interest Coverage Ratio amounted to 0.45 in Q3 2025, which was up 5749.68% from 0.35 recorded in Q2 2025.
  • Esperion Therapeutics' Interest Coverage Ratio's 5-year high stood at 5.15 during Q1 2024, with a 5-year trough of 10.19 in Q1 2021.
  • In the last 5 years, Esperion Therapeutics' Interest Coverage Ratio had a median value of 2.81 in 2023 and averaged 2.2.
  • As far as peak fluctuations go, Esperion Therapeutics' Interest Coverage Ratio skyrocketed by 25253.5% in 2024, and later plummeted by 12206.67% in 2025.
  • Quarter analysis of 5 years shows Esperion Therapeutics' Interest Coverage Ratio stood at 4.14 in 2021, then rose by 28.37% to 2.97 in 2022, then increased by 5.16% to 2.81 in 2023, then skyrocketed by 90.43% to 0.27 in 2024, then tumbled by 67.8% to 0.45 in 2025.
  • Its Interest Coverage Ratio stands at 0.45 for Q3 2025, versus 0.35 for Q2 2025 and 1.14 for Q1 2025.